Literature DB >> 26752145

Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation.

P Thomas1, T Santiago2, M H Dallas3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26752145     DOI： 10.1038/bmt.2015.309

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

Authors:  G Missale; R Bertoni; V Lamonaca; A Valli; M Massari; C Mori; M G Rumi; M Houghton; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.

Authors:  Harrys A Torres; Pearlie P Chong; Marcos De Lima; Mark S Friedman; Sergio Giralt; Sarah P Hammond; Patrick J Kiel; Henry Masur; George B McDonald; John R Wingard; Maya Gambarin-Gelwan
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-06       Impact factor: 5.742

Review 3.  Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Authors: 
Journal:  Hepatology       Date:  2015-08-04       Impact factor: 17.425

Review 4.  Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.

Authors:  Troels K H Scheel; Charles M Rice
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

5.  Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.

Authors:  S I Strasser; D Myerson; C L Spurgeon; K M Sullivan; B Storer; H G Schoch; S Kim; M E Flowers; G B McDonald
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

6.  The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort.

Authors:  Sharon Castellino; Shelly Lensing; Caroline Riely; Shesh N Rai; Rene Davila; Randall T Hayden; Jackie Fleckenstein; Mark Levstik; Shari Taylor; Patrick J Dean; Sarah Kippenbrock; Jennifer Pope; Jeanne Carr; Donald K Strickland; Melissa M Hudson
Journal:  Blood       Date:  2003-12-18       Impact factor: 22.113

7.  Long-term outcome of hepatitis C infection after bone marrow transplantation.

Authors:  Régis Peffault de Latour; Vincent Lévy; Tarik Asselah; Patrick Marcellin; Catherine Scieux; Lionel Adès; Richard Traineau; Agnès Devergie; Patricia Ribaud; Hélène Espérou; Eliane Gluckman; Dominique Valla; Gérard Socié
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

8.  Genomic analysis of the host response to hepatitis C virus infection.

Authors:  Andrew I Su; John P Pezacki; Lisa Wodicka; Amy D Brideau; Lubica Supekova; Robert Thimme; Stefan Wieland; Jens Bukh; Robert H Purcell; Peter G Schultz; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-19       Impact factor: 11.205

Review 9.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Authors:  Barbara Rehermann
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

10.  Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.

Authors:  Eric Lawitz; Mark S Sulkowski; Reem Ghalib; Maribel Rodriguez-Torres; Zobair M Younossi; Ana Corregidor; Edwin DeJesus; Brian Pearlman; Mordechai Rabinovitz; Norman Gitlin; Joseph K Lim; Paul J Pockros; John D Scott; Bart Fevery; Tom Lambrecht; Sivi Ouwerkerk-Mahadevan; Katleen Callewaert; William T Symonds; Gaston Picchio; Karen L Lindsay; Maria Beumont; Ira M Jacobson
Journal:  Lancet       Date:  2014-07-28       Impact factor: 79.321
View more
  5 in total

Review 1.  Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children.

Authors:  Jonathan R Honegger; Charitha Gowda
Journal:  Curr Opin Infect Dis       Date:  2022-07-15       Impact factor: 4.968

Review 2.  The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.

Authors:  Christine Hong Ting Yang; Eric R Yoo; Aijaz Ahmed
Journal:  J Clin Transl Hepatol       Date:  2017-02-07

Review 3.  Human cord blood-derived viral pathogens as the potential threats to the hematopoietic stem cell transplantation safety: A mini review.

Authors:  Ali Noroozi-Aghideh; Maryam Kheirandish
Journal:  World J Stem Cells       Date:  2019-02-26       Impact factor: 5.326

4.  Treatment of Hepatitis C in a Case of Pediatric B-Cell Acute Leukemia.

Authors:  Nikita Jakhar; Akriti Gera; Richa Mittal; Sumit Mehndiratta; Amitabh Singh
Journal:  J Glob Infect Dis       Date:  2021-08-03

Review 5.  Breakthroughs and challenges in the management of pediatric viral hepatitis.

Authors:  Emanuele Nicastro; Lorenzo Norsa; Angelo Di Giorgio; Giuseppe Indolfi; Lorenzo D'Antiga
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.